CCR News Archives
CCR News Archives
2023
- Elaine S. Jaffe receives FASEB Lifetime Achievement Award
- Clinical trial researching therapy for aggressive gliomas
- NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis
- Clinical trial researching therapy for HIV-associated blood cancers
- Clinical trial researches combination drug therapy for B-cell lymphoma of the central nervous system
- Signals released from dying cancer cells accelerate metastatic tumor growth
- Researchers discover the multiple shapes of RNA, a boon for drug design
- New Milestones publication now available
- A rare look into what makes mesothelioma aggressive, and potentially treatable
- Howard A. Young, Ph.D., Elected as 2022 Fellow of the American Association for the Advancement of Science
- In Memoriam: John J. DiGiovanna
- In Memoriam: James M. Phang, M.D.
- Extrachromosomal DNA promotes aggressiveness of small cell lung cancer
- First clinical trial testing a prevention for breast cancer metastasis to the brain yields encouraging results
- 4th NCI Symposium on Cancer Health Disparities - Registration Deadline March 28, 2023!
- 2023 NCI RNA Biology Symposium - Registration and Abstract Submission Now Open!
- INSPIRED Symposium - Registration Now Open!
- Researchers create a novel cancer drug delivery system inspired by bacterial spores
- In Memoriam: Ji Ming Wang, M.D., Ph.D. (1950 – 2022)
2022
- Researchers uncover stable molecular networks inside liver tumors
- Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?
- When chemotherapy interrupts genetic programs critical for neuronal development and activity, cells accrue DNA damage and die
- Researchers exploit novel vulnerability to deprive solid tumors of nutrients
- Clinical trial researching combination drug therapy for multiple myeloma
- New insights into why smoking causes fatty liver disease
- Steven A. Rosenberg selected as Icon in Surgery by ACS
- NCI RNA Biology Initiative Retreat - October 25, 2022
- Biology & Biophysics of the Nucleus Symposium - October 20-21, 2022
- Clinical trial researching therapy for bile duct cancer
- Celebrating Hispanic Heritage Month: A Conversation with Cecilia Monge, M.D., M.P.H., F.A.C.P.
- Celebrating Hispanic Heritage Month: A Conversation with Kylynda Bauer, Ph.D.
- Clinical trial evaluates drug combination for inoperable neuroendocrine tumors
- Clinical trial researching T-cell therapy for sarcoma
- T-cell imbalance can impact immunotherapy outcomes
- Mapping cells’ mechanical properties for insight into metastasis
- Clinical trial researching therapy for tumors that have spread to the lining of the abdomen
- Clinical trial researches drug therapy for bone marrow neoplasms
- Liver cancer may unexpectedly be influenced by platelets
- Clinical trial researching therapy for prostate cancer
- Clinical trial researching therapy for cancers of the reproductive system
- Study finds that enzyme can disentangle strands of DNA and RNA
- New insights into the origins of an aggressive form of lymphoma
- Bacteria inside lung tumors concentrate within cancer cells
- Immune receptors recognizing mutations in p53 could guide immunotherapies for solid tumors
- CCR postdoctoral researcher awarded Fulbright to study HPV and cervical cancer in Africa
- A protein predicts poor breast cancer survival for women of African descent
- New way to classify meningioma brain tumors suggests potential treatments
- 2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology
- Clinical trial researches immunotherapy for recurrent thymoma and thymic carcinoma
- Sung-Yun Pai selected for Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program
- Celebrating Asian American, Native Hawaiian, and Pacific Islander Heritage Month: A Conversation with Lilian Yang, M.B.A.
- Celebrating AANHPI Heritage Month: A Conversation with Suresh Ambudkar, Ph.D.
- Clinical trial researching immunotherapy for B-cell lymphoma
- Celebrating AANHPI Heritage Month: A Conversation with Fatima Karzai, M.D.
- Machine learning reveals rules of T cell activation
- Clinical trial researches CAR T-cell therapy for hairy cell leukemia
- Clinical trials research immunotherapy for Kaposi sarcoma
- In Memoriam: Joost J. Oppenheim, M.D. (1934–2022)
- Four CCR researchers receive high honors
- Elaine S. Jaffe receives HHS Career Achievement Award
- Clinical trial researching PSMA imaging in prostate cancer
- Computational model finds signatures of T cell resilience in solid tumors
- Clinical trial researching therapy for some small cell lung cancers
- Kandice Tanner receives Arthur S. Flemming Award
- Clinical trial researches therapy for VEXAS syndrome
- Protein signature in the blood linked to prostate cancer lethality in men of African ancestry
- Clinical trial researches three-part immunotherapy regimen for gastric or head and neck cancer
- CCR scientists to present at 2022 AACR Annual Meeting in New Orleans
- Clinical trial aims to reduce hormone therapy side effects for people with prostate cancer
- New Milestones publication now available
- First-in-human clinical trial evaluates drug for pancreatic cancer and other solid tumors
- Steven Pavletic named Top Ten Clinical Research Achievement awardee
- Clinical trial studies combination therapy for relapsed/refractory B-cell lymphomas
- Following the fellowship experience with CCR fellow Martha Teke, M.D.
- Following the fellowship experience with CCR fellow Bailey Johnson
- Clinical trial evaluates drug for treatment of neurofibromatosis type 1 and atypical neurofibromas
- Clinical trial compares interval dosing of two immune checkpoint inhibitors
- Unique gene expression profiles identify rare T cells that could be effective in cancer immunotherapy
- NCI study advances personalized immunotherapy for metastatic breast cancer
- Researchers develop new method to estimate cell-type-specific information from bulk tumor data
2021
- Breast cancer stem cells become aggressive upon contact with macrophages
- A high-fiber diet may improve the response of melanoma patients to immunotherapy
- Cell surface molecule could predict how patients respond to immunotherapy
- Clinical trial researches drug combination with immunotherapy for mesothelioma
- Clinical trial targets cell surface protein GPC3 to treat advanced hepatocellular carcinoma
- CCR researchers use immunogenetic profiling to identify targets for numerous pediatric cancers
- Anish Thomas explains the challenges and goals of his small cell lung cancer research
- Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
- Clinical trial studies breast cancer drug abemaciclib as a therapy for Kaposi sarcoma
- Rosenberg, Waldmann named 2021 Fellows of the Academy of Immuno-Oncology
- Gut bacteria sculpt innate immunity within the tumor microenvironment
- A conversation with Hunter Lab members about the Deaf Student Training Program
- Clinical trial evaluates new combination therapy for virus-associated malignancies
- In Memoriam: Thomas A. Waldmann, M.D. (1930-2021)
- New tool helps researchers make sense of complex immune signals
- Newly developed gel can be used to treat cancers that form on organ surfaces
- Clinical trial studies targeted therapy for PARP-resistant tumors and chemotherapy-resistant small cell lung cancer
- Immunotherapy studied in clinical trial for glioblastoma or gliosarcoma
- Clinical trial evaluates reduced dosing of cyclophosphamide to prevent severe acute graft-versus-host disease
- Sandra L. Wolin receives Sandra K. Masur Senior Leadership Award